INTRODUCTION
============

Secretory cargoes of eukaryotic cells are transported from the endoplasmic reticulum (ER) to the Golgi membranes by COPII-coated vesicles ([@B8]; [@B31]). ER-resident KDEL (HDEL in yeast)-containing proteins are transported back to the ER in COPI vesicles by binding the KDEL (HDEL) receptor ([@B34]). Within the Golgi apparatus, there are many exit routes, and secretory cargo must be sorted to ensure that it is delivered to the correct destination. In yeast and higher eukaryotes the trafficking and sorting of secreted proteins from the Golgi membranes remain poorly understood. In the late Golgi membranes of higher eukaryotes, mannose-6-phosphate--containing lysosomal hydrolases bind the mannose-6-phosphate receptor (M6PR) and are packed into clathrin-coated vesicles for export to the endosomes/lysosomes ([@B6]). Sorting of lysosomal hydrolases in yeast also occurs via endosomes and clathrin-coated vesicles, and the best-characterized example is carboxypeptidase Y (CPY), which is sorted by direct interaction with its receptor Vps10 ([@B12]). A distant M6PR orthologue does exist in yeast, Mrl1, which affects transport of some soluble hydrolases, but it is unclear whether this is through a glycan-based interaction as in mammalian cells or through a peptide-based interaction as observed for CPY ([@B61]).

In yeast, there are at least two transport routes from the late Golgi compartment to the cell surface, which have been classified based on vesicle densities, cargoes, and some of the molecular requirements for their biogenesis ([@B22]; [@B15]). The low-density secretory vesicles (LDSVs) are transported directly to the cell surface and contain the soluble cargo Bgl2 and the plasma membrane H^+^ ATPase Pma1, whereas the high-density secretory vesicles (HDSVs) transit through the endosomal system, require clathrin and the dynamin-like GTPase Vps1, and contain invertase and acid phosphatase as cargoes ([@B21]; [@B23]). No receptors for secretory cargo in the Golgi compartments have been identified in yeast or mammals.

More recent studies revealed the involvement of calcium and pH in cargo sorting from the *trans*-Golgi network (TGN). The sorting of the LDSV-specific integral membrane protein Pma1 depends on the pH of the late Golgi membranes in yeast ([@B24]). Calcium homeostasis in the TGN and its role in secretory cargo sorting require the actin filament--severing protein cofilin and the Ca^2+^ ATPase secretory pathway calcium ATPase 1 (SPCA1) in mammalian cells ([@B58], [@B57]). A defect in the activity of these proteins causes retention of some of the secretory cargoes in the TGN, whereas others are exported at normal or higher rates. Of interest, under such conditions, a soluble TGN resident protein, Cab45, and the lysosomal protease cathepsin D are also secreted from the cells ([@B58], [@B57]). These findings are beginning to reveal components of the secretory cargo-sorting machinery from the TGN. However, one key issue is whether cofilin and SPCA1 have a similar role in the sorting of secretory cargo in other organisms. In addition, the yeast Golgi membranes, unlike the mammalian Golgi apparatus, are not stacked, thus raising the question of whether cargo sorting for trafficking to the cell surface in yeast is by a mechanism similar to that in mammalian cells.

Cofilin and actin dynamics clearly regulate endocytosis in yeast ([@B17]). The requirement of cofilin in protein transport from the Golgi apparatus of yeast is not known. Actin, on the other hand, has been implicated in secretion; however, its exact role in this process, or more specifically at the Golgi membranes, is not well understood ([@B40]; [@B39]; [@B26]). Cofilin functions by binding monomeric or filamentous actin and depolymerizing actin filaments and as such regulates the organization of the actin cytoskeleton and cortical actin patches, which are proposed sites of endocytosis in yeast ([@B9]; [@B30]). The regulation of cofilin has similarities in yeast and higher eukaryotes, such as regulation by pH and phosphatidylinositol 4,5-bisphosphate (PIP~2~) binding ([@B55]). Regulation by phosphorylation is an important mechanism of regulation in mammalian cells, although no cofilin kinases or phosphatases have been identified in yeast ([@B38]; [@B1]). However, this may be a conserved mode of regulation, since mutation of the conserved serine residue to glutamate, which would constitutively inactive cofilin, is lethal ([@B30]).

We tested the requirement of cofilin in cargo sorting and export from the Golgi apparatus in *Saccharomyces cerevisiae*. Our findings reveal that cofilin is required for the sorting of select cargo at the late Golgi membranes. The LDSV cargo Bgl2 was found to accumulate in the Golgi membranes of cofilin-mutant cells, whereas Pma1 transport was unaffected. The trafficking of HDSV-specific cargo invertase was mildly affected, whereas the rate of CPY transport to the vacuole was reduced and CPY was secreted from cofilin-mutant cells. Similar sorting defects are described for cells lacking the Golgi apparatus--localized Ca^2+^ ATPase Pmr1, and we report here that a cofilin mutant interacts genetically with loss of *PMR1*. Moreover, exogenous expression of *PMR1* restored the Bgl2 secretion in cofilin-mutant cells. Together these data indicate that cofilin and actin dynamics regulate protein sorting in the yeast Golgi apparatus and likely do so through Pmr1 as in mammalian cells.

RESULTS
=======

Bgl2 secretion is impaired in cofilin mutants
---------------------------------------------

*S. cerevisiae* contains a single cofilin gene, which is essential for viability ([@B30]). A number of mutant alleles of cofilin have been generated, and these have facilitated the analysis of cofilin\'s role in regulation of actin dynamics through the activity of actin filament depolymerization. Many of these cofilin mutants have been generated as recombinant proteins and examined in vitro for various functions such as F- or G-actin binding, actin filament depolymerization, and PIP~2~ binding ([@B29]; [@B30]; [@B42]; [@B35]). Drubin and colleagues generated three cofilin temperature-sensitive (ts) alleles: *cof1-5*, *cof1-8*, and *cof1-22.* The *cof1-22--*mutant protein is defective in F-actin binding, the mutant *cof1-5* protein is defective in G-actin binding, and the *cof1-8*--mutant protein was not characterized for these activities but was later shown to be defective in PIP~2~ binding ([@B29]; [@B30]). Clearly these mutants are severely defective in cofilin function in vivo at the nonpermissive temperature of 37°C, as indicated by dramatic changes in actin organization and defective endocytosis. We tested these alleles for their ability to affect secretion of the cell wall protein Bgl2. Cells were grown to logarithmic phase at 25°C and shifted to 37°C for 2 h before removal of the cell wall and determination of intracellular Bgl2. Bgl2 is secreted rapidly postsynthesis and nearly undetectable in the spheroplasts of wild-type cells. All three cofilin ts alleles accumulated Bgl2 to similar levels as a *sec14-1* ts strain known to block transport of Bgl2 ([Figure 1A](#F1){ref-type="fig"}; [@B14]). We also tested these cofilin mutants at permissive temperatures of 25 and 30°C. The *sec14-1* control only accumulated Bgl2 at the nonpermissive temperature of 37°C, whereas all cofilin ts alleles exhibited a Bgl2 transport defect regardless of temperature ([Figure 1A](#F1){ref-type="fig"}). To discard the possibility of differences in protein translation, we also examined total and extracellular Bgl2. There was no reduction in the extracellular levels of Bgl2 in cofilin mutants or the *sec14-1* control, as Bgl2 is highly abundant in the cell wall, and a complete block in transport over a long period of time would be required to see reduction in the steady-state extracellular levels (Supplemental Figure S1A). Total Bgl2 was determined in nonspheroplasted cells, and overall levels of Bgl2 were virtually unaltered. A slight increase in total Bgl2 compared with controls was observed only at 25°C for *cof1-8*, *cof1-5*, and *cof1-22*, but this did not account for the accumulated internal Bgl2 (Supplemental Figure S1A). Other non--temperature-sensitive alleles, which affect the function of cofilin to a lesser extent, were also tested. For example, two alleles *cof1-18* and *cof1-19* that do not affect in vivo actin organization or growth ([@B30]) also did not affect Bgl2 transport (Supplemental Figure S1B). It has been shown the *cof1-19* allele affects actin patch mobility in vivo, and the mutant protein has defects in PIP~2~ and G-actin binding in vitro, whereas the *cof1-18* mutant protein has no characterized defects ([@B30]; [@B41]; [@B35]). One allele, *cof1-4*, which does not affect growth but affects actin organization (to lesser extent than the ts alleles; [@B30]), did accumulate Bgl2 (Supplemental Figure S1B). The *cof1-4* allele contains a serine-to-alanine mutation in the conserved serine residue known to regulate cofilin function in higher eukaryotes. Together these data indicate that cofilin activity is required for Bgl2 transport. Mildly perturbing cofilin function was not sufficient to result in Bgl2 accumulation, and this phenotype was only observed in those alleles severe enough to lead to noticeable changes in the actin cytoskeleton ([Figure 1](#F1){ref-type="fig"} and Supplemental Figure S1). We chose to focus on the *cof1-8* allele at 30°C for further analysis to maintain a background with relatively high reduction in cofilin activity but less effect on endocytosis compared with *cof1-5* and *cof1-22*, which reportedly exhibit more endocytic problems, even at permissive temperatures ([@B29]; [@B42]). We first determined that the defect in Bgl2 transport in *cof1-8* cells could be restored by exogenous expression of wild-type *COF1* ([Figure 1B](#F1){ref-type="fig"}).

![Cofilin and actin are required for proper secretion of Bgl2. (A) Wild-type, *sec14-1*, and the indicated cofilin mutant cells were grown to logarithmic phase at 25 or 30°C. Cells grown at 25°C were also shifted to 37°C for 2 h. Equal cell numbers were treated to generate spheroplasts, washed to remove the cell wall, and analyzed by Western blot to determine the amount of intracellular Bgl2. (B) Wild-type and *cof1-8* cells expressing empty vector or *COF1* were grown at 30°C and treated as in A to determine the intracellular levels of Bgl2. (C) FM4-64 transport was determined in live cells grown at 30°C or preshifted to 37°C for 1 h. Cells were labeled with 40 μM FM4-64 for 15 min (at 30 or 37°C, respectively). Cells were washed and resuspended in fresh, prewarmed YPD and further incubated at 30 or 37°C for 45 min. Scale bar, 5 μm. (D) Actin organization was examined by staining with phalloidin. Cells were grown at 30°C to logarithmic phase and either fixed directly in 3.7% formaldehyde or shifted to 37°C for 1 h before fixation. Scale bar, 5 μm. (E) Wild-type and *cof1-8* cells were grown to 30°C and treated with 100 μM latrunculin A (Lat-A) or dimethyl sulfoxide (DMSO). Equal cell numbers were taken at the indicated times, and spheroplasts were generated and analyzed by Western blot for detection of Bgl2.](2327fig1){#F1}

To examine the effect of *cof1-8* in endocytosis at the permissive temperature of 30°C, we analyzed the trafficking of the lipophilic dye FM4-64 from the plasma membrane to the vacuole via endosomes. Cells were incubated with FM4-64 for 15 min, washed, and incubated for 45 min to examine the rate of transport to the vacuole via the endosomes. As expected, at the nonpermissive temperature of 37°C, the *cof1-8* mutant failed to internalize the majority of FM-464. However there was no defect in the internalization or the rate of FM-464 transport at the permissive temperature of 30°C ([Figure 1C](#F1){ref-type="fig"}). Next we determined the organization of the actin cytoskeleton in *cof1-8* cells compared with wild type at 30 and 37°C by staining fixed cells with phalloidin. Wild-type cells, regardless of temperature, contained actin patches mostly in the daughter (budding) cell; filamentous actin cables were often observed traversing the mother--bud axis; however, these were less pronounced at 37°C. In *cof1-8* cells at 37°C, the actin cytoskeleton was clearly perturbed, with fewer actin patches that were much larger and depolarized. No actin cables were visible, but instead thick actin structures were observed in nearly all cells. In *cof1-8* cells grown at 30°C, the actin cytoskeleton was much less affected than at 37°C, and although depolarized, it was fairly normal in overall appearance. ([Figure 1D](#F1){ref-type="fig"}). Latrunculin A (Lat-A) blocks actin polymerization and therefore counteracts the activity of cofilin. There was no change in intracellular accumulation of Bgl2 in *cof1-8* cells treated with Lat-A ([Figure 1E](#F1){ref-type="fig"}). On the other hand, 30 min of treatment with Lat-A treatment in wild-type cells resulted in Bgl2 accumulation, indicating that general perturbations in actin dynamics affect Bgl2 export from the Golgi membranes. This is not surprising, as Lat-A treatment has been shown to result in the intracellular accumulation of invertase and post--Golgi compartment vesicles ([@B40]; [@B26]).

A reduced rate of endocytosis does not affect Bgl2 export from the Golgi membranes
----------------------------------------------------------------------------------

To further address the connection between cofilin\'s roles in regulation of endocytosis and secretion, we examined Bgl2 transport in a number of mutants defective in endocytosis. Abp1 and Aip1 are two proteins that function intimately with cofilin in the formation of actin patches and the regulation of endocytosis. Abp1 localizes to sites of endocytosis before cofilin and is required to activate the Arp2/3 complex ([@B42]). Aip1 interacts directly with cofilin and is required to restrict cofilin localization to cortical patches and promote actin filament turnover ([@B11]; [@B35]). As before, intracellular accumulation of Bgl2 was determined in spheroplasted cells. Deletion of either of these proteins did not lead to intracellular accumulation of Bgl2 ([Figure 2A](#F2){ref-type="fig"}). We also examined the secretion of Bgl2 in other endocytic mutants that do not interact directly with cofilin at actin patches but are reportedly blocked in all forms of endocytosis, including receptor-mediated endocytosis, fluid-phase endocytosis, and FM4-64 transport ([@B17]). These included endocytic mutants that function directly at sites of endocytosis (Sla1, Sla2, Inp51, and End3) and endocytic mutants that block endocytosis indirectly by affecting ergosterol synthesis (Erg2, Erg3, and Erg6). Sla1 binds actin and End3, and these are required for cortical actin assembly and endocytosis ([@B51], [@B52]; [@B59]); Sla2 is a transmembrane protein that links actin and clathrin at sites of endocytosis ([@B60]; [@B62]); Inp51 is a PIP~2~ phosphatase of the synaptojanin family that regulates PIP~2~ homeostasis at the plasma membrane (PM) and is required for endocytosis ([@B48]); Erg2 is a sterol isomerase catalyzing an intermediate step in ergosterol biosynthesis ([@B4]); Erg3 is a sterol desaturase, generating a precursor in ergosterol biosynthesis ([@B3]); and Erg6 is a methyltransferase converting zymosterol to fecosterol in the ergosterol biosynthetic pathway and acts upstream of both Erg2 and Erg3 ([@B32]; [@B43]). Of these seven endocytic mutants, only two, *erg6∆* and *sla2∆*, exhibited accumulation of Bgl2 ([Figure 2A](#F2){ref-type="fig"}). Of interest, Sla2 is a clathrin adapter, linking clathrin and actin, and *sla2∆* cells have been shown to accumulate post--Golgi compartment vesicles ([@B39]). The human Sla2 homologue (Hip1R) has also been implicated in transport from the TGN ([@B10]). Erg6 is an enzyme required for ergosterol synthesis, and perturbing ergosterol levels would alter lipid homeostasis in the Golgi membranes, which is known to affect secretion of some cargoes ([@B45]; [@B27]). We suggest that the accumulation of Bgl2 in *erg6∆* and *sla2∆* mutant cells is likely due to direct effects on the function of the Golgi apparatus. Taken together, these data strongly indicate that the defect in Bgl2 secretion in *cof1-8* cells at 30°C is not due to a defect in endocytosis.

![Endocytosis is not required for proper secretion of Bgl2. (A) The indicated endocytosis-defective strains were grown at 30°C to logarithmic phase, spheroplasts were generated, cell walls were removed, and intracellular Bgl2 was examined by Western blot. (B) Snc1-GFP localization was examined in live cells grown to logarithmic phase at 30°C. Scale bar, 5 μm.](2327fig2){#F2}

To further assess defects in endocytosis in *cof1-8* cells at 30°C, we examined the localization of the vesicle soluble *N*-ethylmaleimide--sensitive factor attachment protein receptor (v-SNARE) Snc1. Snc1 is packaged into both HDSV and LDSV transport carriers for export from the Golgi apparatus ([@B21]). After reaching the PM, Snc1 is internalized via endosomes, recycled back to the TGN, and then transported to the PM ([@B33]). As expected, at steady state, in wild-type cells Snc1-GFP was visible at the PM of the growing bud and internal structures previously identified as TGN and endosomes ([Figure 2B](#F2){ref-type="fig"}; [@B46]). However, in *cof1-8* cells at 30°C Snc1-GFP was only visible in the PM, and the localization was no longer polarized to the growing bud but instead was distributed uniformly in the PM of the growing cells ([Figure 2B](#F2){ref-type="fig"}). This implies that the rate of endocytosis and polarized secretion is affected in *cof1-8* cells at 30°C. This is not surprising, since the actin cytoskeleton is also depolarized at this temperature ([Figure 1D](#F1){ref-type="fig"}). Snc1--green fluorescent protein (GFP) localization is often used to assess the rate of endocytosis, and a PM-only localization is a hallmark of a defect in endocytosis. However, when we examined the localization of the Snc1-GFP in the other endocytic mutants described, we observed varying phenotypes. Snc1-GFP localization was similar to *cof1-8* cells in *end3∆* and *sla2∆* cells: only PM and depolarized. A similar phenotype was observed in *sla1∆* cells but to a lesser extent, with some internal punctate structures still visible and a polarized localization. In *inp51∆* cells, Snc1-GFP localization was almost normal, with occasional depolarization. Of interest, *erg3∆* and *erg6∆* cells exhibited more internal Snc1-GFP localization compared with wild type, and *erg3∆* cells had even less signal of Snc1-GFP at the PM than *erg6∆*. However, *erg3∆* and *erg6∆* cells still retained a polarized localization of Snc1-GFP, whereas *erg2∆* cells were virtually indistinguishable from wild type. The two deletion strains defective in Bgl2 transport, *sla2∆* and *erg6∆,* exhibited opposite Snc1-GFP localizations; wild type--like localization in *erg6∆* cells, and PM only in *sla2∆* cells. Steady-state Snc1-GFP localization is dependent on the rate of export from the Golgi membranes, the rate of endocytosis, and the rate of retrieval from endosomes. Clearly a decreased rate of endocytosis does not always lead to a PM-only localization of Snc1-GFP, as observed in *inp51∆*, *erg2∆*, *erg3∆*, and *erg6∆* cells. Loss of function of proteins affecting multiple steps in the Snc1-GFP cycling (which is likely the case for Sla2, Erg6, and cofilin) leads to varying phenotypes.

Bgl2 rate of transport is decreased and accumulates in a late-Golgi compartment in *cof1-8* cells at 30°C
---------------------------------------------------------------------------------------------------------

To determine more precisely whether the rate of Bgl2 transport was affected in *cof1-8* cells and to control for a potential increase in rate of Bgl2 synthesis in *cof1-8* cells, we performed a pulse chase and immunoprecipitation of newly synthesized Bgl2 in intracellular versus extracellular fractions. Wild type and *cof1-8* and cells were labeled at 30°C with \[^35^S\]methionine for 5 min and chased with 50 mM methionine for 0, 10, and 30 min (*sec14-1* cells were labeled in the same way but at 37°C, with a 30-min pre-shift to this temperature). In wild-type cells Bgl2 is clearly secreted much faster when compared with *cof1-8* and *sec14-1* cells ([Figure 3A](#F3){ref-type="fig"}). Results of three independent experiments were quantitated, and the percentage of internal Bgl2 compared with total (intracellular and extracellular) was plotted over time. At time 0 wild-type cells had 90.0% Bgl2 internal, compared with 95.3 and 94.1% for *cof1-8* and *sec14-1* cells, respectively, indicating that during the 5-min pulse period wild-type cells secreted ∼5% more than either mutant. By 10 min postchase, wild-type cells contained 46.3% internal Bgl2, compared with 66.9% in *cof1-8* cells and 81.8% in *sec14-1* cells, and by 30 min postchase, the difference in the rate of Bgl2 secretion was even more pronounced, with wild-type cells only retaining 12.1% of total Bgl2 internally, compared with 49.2 and 62.4% in *cof1-8* and *sec14-1* cells, respectively ([Figure 3B](#F3){ref-type="fig"}). Therefore the accumulation of internal Bgl2 observed in *cof1-8* cells is due to a decreased rate of transport and not to increased Bgl2 expression in *cof1-8* cells compared with wild type.

![Bgl2 rate of transport is decreased and accumulates in a late Golgi compartment. (A) Bgl2 rate of transport was determined in wild-type and *cof1-8* cells at 30°C and *sec14-1* cells at 37°C by pulse-chase labeling of newly synthesized protein with \[^35^S\]methionine. Equal cell numbers were labeled with 100 μCi/time point, spheroplasts were generated, and Bgl2 was immunoprecipitated from intracellular and extracellular fractions at the indicated times and detected by SDS--PAGE/autoradiography. (B) Results of three independent Bgl2 pulse-chase and immunoprecipitations were quantitated, and the sum of internal and external fractions at a given time point was taken as 100%. The percentage internal Bgl2 was plotted vs. time using GraphPad Prism software. Error bars represent SEM. (C) Wild-type, *cof1-8*, and *bgl2Δ* cells were grown to logarithmic phase at 30°C. Cells were fixed in formaldehyde, spheroplasted, and permeabilized for indirect immunofluorescence staining with anti-Bgl2 antibody (green). Nuclei were stained with 4′,6-diamidino-2-phenylindole (blue), and the samples were slightly overexposed to clearly show the cells in wild type and *bgl2Δ*. Scale bar, 3 μm. (C) *cof1-8* cells were grown at 30°C expressing the indicated Golgi membrane (Sec7-DsRed, *trans*-Golgi membrane; Anp1--red fluorescent protein \[RFP\], early Golgi membrane) and endosome (mCherry-Pep12 and mCherry-Tlg1) markers. Cells were treated as in B for immunofluorescence staining with anti-Bgl2 antibody (green) and anti-RFP (red) to detect the marker protein. Stacks of images were taken and treated with deconvolution software to reduce the background signal. Scale bar, 3 μm.](2327fig3){#F3}

To determine the intracellular location of the Bgl2 in *cof1-8* cells, we tested its location with respect to ER and Golgi membranes. Wild-type and *cof1-8* cells grown at 30°C were spheroplasted and homogenized, and the membrane-bound compartments were fractionated to equilibrium on a continuous 30--60% sucrose gradient. The accumulation of Bgl2 in *cof1-8* cells compared with wild type was readily reproducible in the fractioned membranes, and ER and Golgi membranes were separated by this method. The Bgl2-containing fractions were clearly excluded from the ER and followed a Golgi membrane--like distribution. The results of three independent gradients were compiled and plotted (Supplemental Figure S2). To further ascertain the location of Bgl2 in *cof1-8* cells, we visualized endogenous Bgl2 by immunofluorescence microscopy using a purified anti-Bgl2 antibody. Cells were grown at 30°C and fixed in formaldehyde, and extracellular Bgl2 was removed by digestion of the cell wall before permeabilization and detection by immunofluorescence. In *cof1-8* cells, Bgl2-containing punctate structures were easily observed. Such structures were only evident in wild-type cells with increased exposure, whereas *bgl2∆* control cells contained no such elements ([Figure 3C](#F3){ref-type="fig"}). Colocalization with Golgi membranes and endosome markers in *cof1-8* cells revealed Bgl2 in a compartment closely apposed to the late Golgi membrane--specific marker Sec7-RFP, whereas no such proximity was observed with the early Golgi membrane marker Anp1-RFP or the endosome marker Pep12-RFP or Tlg1-RFP ([Figure 3D](#F3){ref-type="fig"}). Together these data indicate that Bgl2 accumulates in *cof1-8* cells in a late Golgi compartment.

Cargo-selective effect on secretion in *cof1-8* cells
-----------------------------------------------------

To determine whether cofilin affects protein secretion in general, we asked whether the *cof1-8* allele affected total secretion of proteins into the medium at the permissive temperature of 30°C. Wild-type and *cof1-8* cells were labeled with \[^35^S\]methionine for 10 min, and this pulse medium was replaced with chase medium containing 50 mM methionine to clearly see the rate of protein transport during 10-, 30-, and 60-min chase periods. Cells with a ts allele of the gene encoding *N*-ethylmaleimide (NEM)--sensitive factor, *sec18-1*, were cultured in the same way but shifted to the nonpermissive temperature of 37°C at 1 h before and during the pulse chase as a control to block secretion ([@B20]). There were no obvious changes in the total levels of proteins secreted, indicating that *cof1-8* cells do not exhibit a general block in protein secretion. There were some minor differences between the proteins secreted into the medium from wild-type and *cof1-8* cells at the 30-min time point, with three bands present in higher amounts (labeled +) and four bands present in lower amounts (labeled --); however, these differences were virtually undetectable at the 60-min time point, indicating there may be differences in the rate of secretion of some proteins but not in the overall amounts secreted ([Figure 4A](#F4){ref-type="fig"}).

![General secretion is not blocked in *cof1-8* cells, but some cargoes are specifically affected. (A) Proteins secreted in the medium of wild-type and *cof1-8* cells grown at 30°C and *sec18-1* cells grown at 30°C and preshifted to 37°C for 1 h were detected by pulse-chase labeling of newly synthesized proteins. Cells were labeled with 150 μCi/ml \[^35^S\]methionine for 10 min. The pulse medium was removed and replaced with chase medium containing 50 mM methionine for 10, 30, and 60 min. Secreted proteins in the medium were precipitated with TCA and detected by SDS--PAGE/autoradiography. Bands labeled (+) are secreted at higher rates and bands labeled (--) are secreted at lower rates in *cof1-8* cells. These differences were much less pronounced at 60 min. (B) Invertase rate of transport was determined in wild-type and *cof1-8* cells at 30°C by pulse-chase labeling of newly synthesized protein with \[^35^S\]methionine. Cells were cultured in SC-methionine and 0.1% glucose for 15 min before (and during) labeling, equal cell numbers were labeled with 100 μCi/ time point, spheroplasts were generated, and invertase was immunoprecipitated from intracellular and extracellular fractions at the indicated times and detected by SDS--PAGE/autoradiography. (C) Transport of newly synthesized Pma1 at 30°C was determined in cells expressing Pma1-HA under the control of the *MET25* methionine-repressible promoter. Synthesis was induced by washing cells free of methionine, and samples were fixed, spheroplasted, and permeabilized at the indicated time points for indirect immunofluorescence staining with anti-HA antibody. Scale bar, 5 μm.](2327fig4){#F4}

To further determine cofilin\'s ability to affect export of proteins from the Golgi membranes, we tested a number of other cargoes directly that are transported by various routes from the Golgi apparatus. Invertase, a soluble enzyme of the periplasmic space, is secreted in response to glucose deprivation and known to be transported by HDSV ([@B22]). The activity of invertase was measured in intact cells (extracellular pool) versus lysed cells (total) to determine the percentage of invertase secreted by cells starved of glucose for 2 h. Wild-type cells secreted 82% of invertase, whereas *sec14-1* cells (grown and starved at nonpermissive temperature), known to block transport of this enzyme, exhibited 36% secretion ([@B5]). However, *cof1-8* cells exhibited a modest decrease in invertase secretion, to 69%, and this was only marginally statistically significant (p = 0.04; Supplemental Figure S3A). To determine more precisely the rate of transport of invertase, we performed pulse-chase and immunoprecipitation of newly synthesized invertase. After 15 min of glucose deprivation, cells were labeled with \[^35^S\]methionine for 5 min and then incubated with 50 mM methionine for 0, 10, and 30 min. Invertase was then immunoprecipitated from intracellular and extracellular fractions. Invertase is core glycosylated in the ER and is hyperglycosylated within the Golgi apparatus. In wild-type cells invertase was completely secreted in a hyperglycosylated form by 10 min postchase, with no detectable internal invertase. The *cof1-8* cells exhibited a decrease in the amount of secreted invertase, and a very small amount of hyperglycosylated invertase was still present intracellularly at 10 and 30 min postchase ([Figure 4B](#F4){ref-type="fig"}). This correlates well with the slight decrease we observed by measuring activity after 2 h of glucose deprivation and also indicates that this effect is due to a decrease in the rate of transport at the level of the Golgi apparatus.

The plasma membrane H^+^ ATPase Pma1 is transported from the TGN via LDSV ([@B22]). We expressed Pma1-GFP in wild-type and *cof1-8* cells and visualized its location by fluorescence microscopy. As expected, in wild-type cells Pma1-GFP localized uniformly in the plasma membrane. In *cof1-8* cells grown at 30°C the localization of Pma1-GFP was unaffected, indicating that there is not a complete block in the LDSV pathway and no missorting of Pma1-GFP to the vacuole (Supplemental Figure S3B). However, as Pma1 is very stable at the PM, it is possible there are differences in the rate of transport not detectable by this method. Therefore we examined the localization of hemagglutinin (HA)-Pma1 under the control of *MET25* promoter by immunofluorescence microscopy. HA-Pma1 reaches the PM after 90 min of derepression in methionine-free medium ([@B36]), and therefore we examined the localization after 30 and 60 min. Unfortunately, we were unable to detect intermediate steps (ER and Golgi membranes) of HA-Pma1 transport by this method, which was likely complicated by the fact that under repressing conditions a very low level of HA-Pma1 was detectable (even when double repressing amounts of methionine were used), and this was more pronounced in the wild-type cells ([Figure 4E](#F4){ref-type="fig"}). Similarly, upon derepression, the overall expression level of HA-Pma1 was somewhat higher in wild-type cells compared with *cof1-8* cells. Despite these slight differences in the expression of HA-Pma1, there was no major difference in the rate of transport of newly synthesized HA-Pma1, as both 30- and 60-min time points showed mostly PM staining in wild-type and *cof1-8* cells, although we cannot exclude the possibility of a minor kinetic delay that could not be detected by this method ([Figure 4C](#F4){ref-type="fig"}). Hxt1-CFP and Can1 are transmembrane proteins of the plasma membrane, and whereas the route for their transport from the TGN to the cell surface is not known, there was no defect in their trafficking in *cof1-8* cells when compared with wild type (unpublished data). These findings indicate that the *cof1-8* allele affects protein sorting at the Golgi apparatus, since the rate of transport of some cargoes leaving the Golgi membrane was affected without a general block in secretion or in the trafficking of a specific subset of Golgi membrane--derived vesicles destined to the cell surface.

The role of Pmr1 in cofilin-dependent Bgl2 secretion
----------------------------------------------------

Pmr1 is the yeast orthologue of SPCA1, a Ca^2+^/Mn^2+^ ATPase localized to the Golgi apparatus ([@B2]). Yeast cells lacking Pmr1 display various phenotypes associated with Golgi apparatus dysfunction, including secretion of heterologous yeast/mammalian proteins normally retained internally, secretion of CPY, and a defect in glycosylation ([@B47]; [@B2]; [@B16]; [@B7]). We previously identified SPCA1 as a downstream component of cofilin/actin--dependent protein sorting in human cells ([@B57]). We therefore asked whether Pmr1 in yeast cells was also involved in cofilin-dependent cargo sorting from the late Golgi membranes. First we examined transport of CPY in *pmr1∆* and *cof1-8* cells. CPY is transported from the ER to the vacuole via the Golgi apparatus ([@B54]). Secretion of CPY extracellularly can occur if there is a block or delay in CPY transport from the late Golgi compartment to vacuole via endosomes, a phenotype previously reported for *cof1-22* cells ([@B42]) and *pmr1∆* cells ([@B7]). We tested whether *cof1-8* cells grown at 30°C secreted CPY. Yeast harboring the indicated mutations and the wild-type cells were grown on solid medium on nitrocellulose filters for 48 h. Filters were removed and tested for the presence of secreted CPY by Western blotting. Both *pmr1∆* and *cof1-8* cells secreted CPY, similar to the vacuolar protein-sorting mutants *vps4∆* and *vps27∆*, whereas wild-type cells did not ([Figure 5A](#F5){ref-type="fig"}). CPY transport from the ER to Golgi apparatus results in the conversion from p1 to p2 form of CPY, and further transport to the vacuole leads to proteolytic processing of CPY to the mature form ([@B54]). The rate of CPY transport was assessed in *cof1-8* and *pmr1∆* cells grown at 30°C by pulse-chase analysis. Cells were labeled for 5 min with \[^35^S\]methionine and chased with 50 mM methionine for 0, 10, and 20 min, and CPY was immunoprecipitated from the lysates. Trafficking and processing of CPY occurs rapidly in wild-type cells, and by 10 min postchase all CPY was processed to the mature, vacuolar form. In *cof1-8* cells, CPY trafficking was delayed, and at the 10-min time point all three forms were detected ([Figure 5B](#F5){ref-type="fig"}). However, by 20 min postchase nearly all CPY was found in the mature form in *cof1-8* cells. The decreased rate of CPY transport was even more pronounced in *pmr1∆* cells, and at the 20-min time point a significant amount of CPY was still in the unprocessed form ([Figure 5B](#F5){ref-type="fig"}). Therefore this decrease in the rate of CPY transport leads to its secretion from the Golgi membranes, further indicating a defect in protein sorting and not complete block of transport from the Golgi membranes in *cof1-8* cells.

![*cof1-8* and *pmr1∆* cells have a synthetic sickness and share protein-sorting phenotypes. (A) Yeast cells were grown in YPD to logarithmic phase, and equal cell numbers were spotted on YPD solid medium and allowed to dry, and a nitrocellulose filter was overlaid for 48 h at 30°C. Secreted CPY was detected on the filter by Western blot against CPY. (B) CPY transport at 30°C was examined in wild-type, *cof1-8*, and *pmr1∆* cells by pulse-chase labeling of newly synthesized protein with \[^35^S\]methionine. Equal cell numbers were labeled with 100 μCi/time point, and CPY was immunoprecipitated from lysates at the indicated times and detected by SDS--PAGE/autoradiography. (C) The indicated strains were grown to logarithmic phase at 25°C, and equal cell numbers were serially diluted and spotted on YPD medium and further incubated at 25 or 30°C for 48 h. (D) Yeast strains expressing the indicated vectors were grown to logarithmic phase, and equal cell numbers were serially diluted and spotted on selection medium to maintain plasmids and incubated 48 h at 30°C. (E, F) Cells were grown to logarithmic phase at 30°C, and equal cell numbers were treated to generate spheroplasts and washed to remove the cell wall; spheroplasts were analyzed by Western blot to determine the amount of intracellular Bgl2. Quantitation of Bgl2 was performed and normalized to Pgk1 loading control. Amounts relative to wild type were determined for three independent experiments, analyzed, and plotted using GraphPad Prism software. Error bars represent SEM.](2327fig5){#F5}

Then we tested whether cofilin and *PMR1* exhibit a genetic interaction. Double-mutant *pmr1∆ cof1-8* strains were generated and tested by serial dilution for growth. There was a slight growth defect in the double mutant compared with single mutants at 25°C, and at 30°C a strong synthetic sickness was observed ([Figure 5C](#F5){ref-type="fig"}). To test the specificity of the genetic interaction, double-mutant *pmc1∆ cof1-8* strains were generated. Pmc1 is a homologue of Pmr1 that localizes to the vacuole ([@B13]). Pmc1 and Pmr1 can functionally complement one another, as either single deletion is viable, but a strain lacking both Pmr1 and Pmc1 is not viable ([@B13]). Cells with *pmc1∆ cof1-8* did not exhibit any synthetic sickness as observed in *pmr1∆ cof1-8* cells ([Figure 5C](#F5){ref-type="fig"}). Furthermore, the growth defect in *pmr1∆ cof1-8* cells at 30°C could be restored by expression of wild-type *COF1* and/or *PMR1* ([Figure 5D](#F5){ref-type="fig"}).

The cofilin mutants and *pmr1∆* cells secrete CPY. Therefore we examined secretion of Bgl2 and invertase in *pmr1∆* cells, as described. Secretion of invertase was only mildly affected in *cof1-8* cells, at 69 compared with 82% in wild-type cells ([Figure 4B](#F4){ref-type="fig"}). Similarly, in *pmr1∆* cells invertase was unaffected, secreting 79% (unpublished data). Bgl2 secretion was also affected in *pmr1∆* cells, although not to the extent observed in *cof1-8* cells ([Figure 5E](#F5){ref-type="fig"}). However, statistical analysis of multiple experiments revealed that the increased intracellular Bgl2 accumulation observed in *pmr1∆* cells was slightly significant ([Figure 5E](#F5){ref-type="fig"}). In addition, in the *cof1-8 pmr1∆* cells the accumulated Bgl2 was increased, and this was also statistically significant compared with *cof1-8* cells alone ([Figure 5E](#F5){ref-type="fig"}). *pmr1∆* cells display a compensatory increase in *PMC1* expression, and Pmc1 localizes not only to the vacuole, but also to Golgi membranes, where it aids in maintaining calcium homeostasis in the absence of Pmr1 ([@B37]). If Bgl2 transport is dependent on proper calcium levels in the Golgi apparatus and these are only partially perturbed in *pmr1∆* due to Pmc1 activity, then this could account for the milder accumulation of Bgl2 in *pmr1∆* cells compared with *cof1-8.* The increased accumulation of Bgl2 observed in *cof1-8 pmr1∆* cells indicates that cofilin still functions to regulate calcium homeostasis of the Golgi apparatus in the absence of Pmr1, and this is likely through the relocalized Pmc1. In addition, we found that overexpression of exogenous *PMR1* in *cof1-8* cells could restore the transport of Bgl2 ([Figure 5F](#F5){ref-type="fig"}), further supporting that Pmr1 acts downstream of cofilin in regulating transport of Bgl2.

DISCUSSION
==========

Our findings reveal the requirement of cofilin for the secretion of the cell wall--specific protein Bgl2 from the late Golgi compartment. Mutant cofilin (*cof1-8* allele) also affected the sorting of CPY from the Golgi membranes, similar to the finding in mammalian cells, in which cofilin knockdown led to cathepsin D secretion ([@B58]). Many other proteins were exported from the late Golgi membranes normally in *cof1-8* cells, although some differences in the rate of transport were observed, again mimicking the observed phenotype in mammalian cells ([@B58]). As cofilin is essential, we must work with mutant alleles, which obviously retain some function. This may account for the fact that we do not see more protein-sorting events affected in *cof1-8* cells. The situation is further complicated in yeast, as it is known that they can reroute a number of cargoes between different secretory pathways when one is not available. For example, invertase, which normally follows the HDSV-clathrin--dependent pathway, can be transported by the LDSV when necessary, and similarly, when CPY cannot be transported to the vacuole by the HDSV pathway, it is secreted by the LDSV pathway ([@B21]). We observed a mild defect in the secretion of invertase in *cof1-8* cells, which may be a reflection of this rerouting, as CPY transport was also affected in *cof1-8* cells. The following data suggest a direct role for cofilin in the selective sorting/export of the secretory cargo from the late Golgi compartment:Bgl2 and CPY trafficking is affected in the *cof1-8* mutant even at the permissive temperature of 30°C. At this temperature, there is a milder defect in endocytosis, since FM4-64 was endocytosed at a normal rate in *cof1-8* cells, although the steady-state localization of the v-SNARE Snc1-GFP was altered and mostly visible at the plasma membrane.Many of the endocytic mutants have no effect on the trafficking from the Golgi apparatus to the cell surface and display varying Snc1-GFP localizations, indicating that defective endocytosis cannot account for the sorting defects in *cof1-8* mutants. The two proteins that show a clear phenotype for transport of Bgl2 are Sla2 and Erg6. Sla2 and the mammalian orthologue Hip1R have been implicated in export of cargo at the TGN ([@B39]; [@B10]). Sterols are important for trafficking out of the Golgi membranes in both mammalian and yeast cells, and the requirement of Erg6 in Bgl2 export is further proof of this requirement in selective cargo export from the Golgi apparatus ([@B45]).Bgl2 and Pma1 are transported in the same class of vesicles from the Golgi apparatus to the cell surface ([@B22]). The fact that *cof1-8* does not affect trafficking of Pma1 strongly suggests that the defect is in the sorting and/or packing of Bgl2 and not in the budding or the departure of the specific vesicles from the late Golgi compartment.Bgl2 rate of transport is decreased, and it is retained in a late Golgi compartment, which further supports our proposal that cofilin is required for the sorting of secretory cargo in the late Golgi membranes.

Cofilin and Pmr1 function in the same sorting pathway at the Golgi apparatus
----------------------------------------------------------------------------

Pmr1 was first identified in a screen for "supersecreting" mutants based on elevated secretion levels of heterologously expressed proteins ([@B49]). The protein was then characterized as a Ca^2+^ ATPase localized to the Golgi apparatus and identified as orthologue of human SPCA1 ([@B2]; [@B16]; [@B53]). Defects associated with loss of Pmr1 in yeast can be complemented by expression of human SPCA1 in yeast, indicating a conserved function in eukaryotic cells for the Ca^2+^/Mn^2+^ ATPases of the Golgi membranes ([@B50]; [@B53]). In addition, we recently showed SPCA1 functions in a cofilin/actin--dependent sorting mechanism of secretory cargo at the TGN in mammalian cells ([@B57]).

Pmr1 was shown to affect vacuolar protein sorting, and loss of *PMR1* and *cof1-8* show synthetic sickness, which affirms the role of these two proteins in a similar pathway. Moreover, *pmr1∆ cof1-8* double mutants show a more severe effect on the secretion of Bgl2 from the late Golgi membranes compared with that observed in either of the single mutants alone. Taken alone, these findings are confusing, as we would not expect an increase Bgl2 accumulation if Pmr1 acts downstream of cofilin. Similarly, we would expect at least the same defect in Bgl2 transport in *pmr1∆* cells as is observed for *cof1-8.* The vacuolar Ca^2+^ ATPase Pmc1 forms an essential pair with Pmr1, indicating that loss of both calcium pumps leads to lethal mis-maintenance of overall calcium homeostasis ([@B13]; [@B37]). Of interest, it has been shown that a portion of Pmc1 is retained in the Golgi membranes when Pmr1 is not present, and this could account for the mild effect in Bgl2 transport observed in *pmr1∆* cells. *cof1-8* and *pmc1∆* do not show a synthetic genetic interaction as observed in *cof1-8 pmr1∆* cells, although Pmc1 can aid in maintaining Golgi membrane calcium homeostasis and may be able to function downstream of cofilin in regulating sorting of Bgl2 from the TGN, as *cof1-8 pmr1∆* cells showed an increased accumulation of Bgl2 compared with either individual mutant. The fact that overexpression of *PMR1* in *cof1-8* cells rescued the Bgl2 secretion defect strongly indicates the involvement of Pmr1 downstream of the cofilin-dependent cargo sorting in the Golgi membranes.

It is noteworthy that Pma1 and Bgl2, which are transported in the same carriers from Golgi membranes to the cell surface, have different requirements for their sorting: the sorting of Pma1 is pH dependent, whereas Bgl2 export depends on Ca^2+^ ([@B24]). This highlights the importance of ion homeostasis in the sorting of specific secretory cargo in the late Golgi compartments.

Taken together, these new findings suggest that the function of cofilin/actin and the Ca^2+^ ATPase Pmr1/SPCA1 in secretory cargo sorting in the late Golgi membranes is conserved in eukaryotic cells. The obvious next challenge is to identify events that are triggered by the cofilin- and Pmr1/SPCA1-dependent Ca^2+^ import into the late Golgi compartments. Does binding of Ca^2+^ change the properties of specific cargoes and enable their packing into transport carriers destined to the cell surface? Is there a specific protein (receptor) that binds specific cargoes in a Ca^2+^-dependent manner and packs them into the budding transport carriers? What is the precise role of actin in this process? Is it required for the activation of Pmr1 or generation of a specific domain that sequesters the secretory cargo sorting machinery? Yeast is a good system to search for proteins involved specifically in the export of Bgl2 and could reveal the identity of components of the Ca^2+^-dependent cargo sorting in the late Golgi membranes.

MATERIALS AND METHODS
=====================

Media
-----

Yeast cells were grown in rich YPD (1% yeast extract, 2% peptone, and 2% glucose) or synthetic complete (SC) media (0.67% yeast nitrogen base, 2% glucose supplemented with amino acid drop-out mix from Sigma-Aldrich \[St. Louis, MO; lacking uracil, histidine, leucine and tryptophan\] or Clontech \[Mountain View, CA; lacking methionine\]), with required amino acids for auxotrophies and/or plasmid selection added as required.

Yeast strains and plasmid construction
--------------------------------------

Cofilin mutant strains were acquired from David Drubin (University of California, Berkeley) and sequenced to confirm the mutation. The *cof1-8* mutant was not correct upon sequencing, and to maintain isogenic strains a *cof1-8* strain in the background of BY4741 was obtained from Charlie Boone (University of Toronto, Toronto, Canada) and used for all analyses (see [Table 1](#T1){ref-type="table"}). Strains ACY4, ACY18, and ACY19 were generated by homologous recombination of two PCR-generated fragments, one containing 80 base pairs upstream of the *cof1-8* allele to the STOP plus the beginning of the NatNT2 cassette from vector pYM17 ([@B25]) and a fragment containing the NatNT2 cassette plus 45 base pairs downstream of *COF1* locus. Fragment 1 was amplified from genomic DNA from the *cof1-8*, KanMx4 strain using primers 5′-GGAAACAAGAAAAGACTGGTTAGCAACTAC-3′ and 5′-TAATTAACCCGGGGATCCGTCGACCTGCAGCGTACG**TTAATGAGAACCAGCGCCTCTGCTGACTCT**-3′ (*COF1* sequence in bold). Fragment 2 was amplified using pYM17 as template and primers 5′-CGTACGCTGCAGGTCGACGGATCC-3′ and 5′-**TTTCATTTTTCTTGAAGATTGTTGTCATTTGTGAAATCATTTACC**ATCGATGAATTCGAGCTCGATTAC-3′ (downstream *COF1* sequence in bold). Strains were assessed for temperature sensitivity and confirmed by sequencing of the *COF1* gene. To construct the *COF1* plasmid, wild-type *COF1* was amplified from genomic DNA from START to STOP using primers 5′-CTAGCTACTAGT**ATGTCTAGATCTGGGTATGC**-3′ and 5′-CTAGCTCTCGAGT**TAATGAGAACCAGCGCCTCTG**-3′ (*COF1* sequences in bold) and cloned into a pRS416 vector containing the *ADH1* promoter and *CYC1* terminator (provided by Sebastion Leon, Université Paris Diderot, Paris, France) using *Spe*I and *Xho*I restriction enzymes (New England BioLabs, Ipswich, MA).

###### 

Yeast strains used in this study.

  Strain      Genotype                                                                 Source
  ----------- ------------------------------------------------------------------------ --------------------------------------------------------
  BY4741      *MATa his3∆1 leu2∆0 ura3∆0 met15∆0*                                      EUROSCARF
  BY4742      *MATα his3∆1 leu2∆0 ura3∆0 lys2∆0*                                       EUROSCARF
  *cof1-8*    BY4741 *cof1-8,* KanMx4                                                  Charlie Boone
  Wild type   *MATα cof1-4 ura-52 his3Δ200 leu2-3, 112 lys2-801 ade2-101*              David Drubin
  *cof1-4*    *MATα cof1-4, LEU2 ura-52 his3Δ200 leu2-3, 112 lys2-801 ade2-101*        David Drubin
  *cof1-5*    *MATα cof1-5, LEU2 ura-52 his3Δ200 leu2-3, 112 lys2-801 ade2-101*        David Drubin
  *cof1-22*   *MATα cof1-22, LEU2 ura-52 his3Δ200 leu2-3, 112 lys2-801 ade2-101*       David Drubin
  *cof1-18*   *MATα cof1-18, LEU2 ura-52 his3Δ200 leu2-3, 112 lys2-801 ade2-101*       David Drubin
  *cof1-19*   *MATα cof1-19, LEU2 ura-52 his3Δ200 leu2-3, 112 lys2-801 ade2-101*       David Drubin
  *sla1∆*     BY4742 *sla1*∆::KanMx4                                                   EUROSCARF
  *sla2∆*     BY4742 *sla2*∆::KanMx4                                                   EUROSCARF
  *inp51∆*    BY4742 *inp51*∆::KanMx4                                                  EUROSCARF
  *end3∆*     BY4742 *end3*∆::KanMx4                                                   EUROSCARF
  *erg2∆*     BY4742 *erg2*∆::KanMx4                                                   EUROSCARF
  *erg3∆*     BY4742 *erg3*∆::KanMx4                                                   EUROSCARF
  *erg6∆*     BY4742 *erg6*∆::KanMx4                                                   EUROSCARF
  Anp1-RFP    *MATα ANP1-RFP*, KanMx6 *his3∆1 leu2∆0 ura3∆0 lys2∆0*                    Erin O\'shea (Harvard Cambridge, MA)
  ACY4        *MATα ANP1-RFP*, KanMx6 *cof1-8*, natNT2 *his3∆1 leu2∆0 ura3∆0 lys2∆0*   This study
  *pmr1∆*     BY4742 *pmr1∆*::KanMx4                                                   EUROSCARF
  *pmc1∆*     BY4742 *pmc1∆*::KanMx4                                                   EUROSCARF
  ACY18       BY4742 *pmr1∆*::KanMx4 *cof1-8*, natNT2                                  This study
  ACY19       BY4742 *pmc1∆*::KanMx4 *cof1-8*, natNT2                                  This study
  SF282-1D    *MATa sec18-1 mal mel gal2 CUP1 SUC2*                                    Randy Schekman
  CMY505      BY4741 *sec14-1*, NatMx4                                                 Chris McMaster (Dalhousie University, Halifax, Canada)

EUROSCARF, European *Saccharomyces cerevisiae* Archive for Functional Analysis, Institute for Molecular Biosciences, Johann Wolfgang Goethe-University Frankfurt, Frankfurt, Germany.

Bgl2 accumulation
-----------------

Bgl2 accumulation was performed as described with minor modifications ([@B28]). Cells were cultured in YPD or SC to select for various plasmids at 30°C to logarithmic phase, and equal cell numbers were harvested by centrifugation at 2000 × *g* for 5 min. Cell pellets were resuspended in 10 mM NaN~3~/NaF solution and incubated on ice for 10 min, harvested at 10, 000 × *g* for 1 min, resuspended in fresh pre-spheroplasting buffer (100 mM Tris-H~2~SO~4~, pH 9.4; 50 mM β-mercaptoethanol; 10 mM NaN~3~; 10 mM NaF) and further incubated on ice for 15 min. Cells were harvested as before, washed once in spheroplast buffer without zymolyase (50 mM KH~2~PO~4~-KOH, pH 7.4; 1.4 M sorbitol; 10 mM NaN~3~), resuspended in spheroplast buffer containing 167 μg/ml zymolyase 100T (Seikagaku Biobusiness, Tokyo, Japan), and incubated with gentle mixing for 30 min at 30°C. Spheroplasts were harvested by centrifugation at 5000 × *g* for 10 min and resuspended in 1× SDS sample buffer before separation by SDS--PAGE and Western blotting to detect Bgl2 (a gift from Randy Schekman, University of California, Berkeley) and Pgk1 loading control (Invitrogen).

Invertase secretion
-------------------

Invertase secretion was performed using standard methods ([@B18]) with minor modifications. Yeast cells were grown to logarithmic phase at 30°C in YPD, and equal cell numbers were collected by centrifugation at 2000 × *g* for 5 min. Cell pellets were washed twice, resuspended in 0.1% glucose YPD, and cultured for 2 h further at 30°C to induce *SUC2* gene expression. Cells were harvested as before, washed twice, and resuspended in cold 10 mM NaN~3~. An equal cell number was transferred to two new tubes---one containing 10 mM NaN~3~ to keep cells intact (secreted fraction) and the other containing 10 mM NaN~3~ plus 0.2% Triton X-100 to lyse cells (total internal and secreted fractions). In triplicate, equal cell numbers of secreted and total samples were used to assay invertase activity in 0.1 M sodium acetate (pH 5.1). Tubes were equilibrated at 30°C, and 2.5 mol of sucrose (invertase substrate) was added in timed intervals to start the reaction. Exactly 30 min later the reaction was terminated by the addition of 0.2 M sodium phosphate (pH 7.0) with 10 mM NEM and boiling for 3 min. The glucose produced by the invertase was measured by standard glucose oxidase reaction. Tubes were equilibrated at 30°C, and fresh glucostat reagent (0.1 M potassium phosphate, pH 7.0, 4.34 U glucose oxidase, 2.5 μg/μl, 0.1 mM NEM, 150 μg/ml *O*-dianisidine, and 1 mg/ml horseradish peroxidase) was added in timed intervals. Samples were incubated at 30°C for a maximum of 30 min (less, if color change was observed quickly), and the reaction was terminated with the addition of 12 N H~2~SO~4~ before reading absorbance at 540 nm.

\[^35^S\]methionine labeling of secreted proteins
-------------------------------------------------

Cells were grown SC-methionine to logarithmic phase at 30°C (and shifted to 37°C for 1 h in the case of *sec18-1* control), labeled for 15 min with 150 μCi/ml \[^35^S\]methionine, and chased with 50 mM methionine for 30 min. Secreted proteins in the medium were precipitated with trichloroacetic acid (TCA) and detected by SDS--PAGE/autoradiography.

CPY secretion filter assay
--------------------------

Yeast cells were grown in YPD to logarithmic phase, and equal cell numbers (5 μl of 1 OD) were spotted on YPD solid medium; a nitrocellulose filter was overlaid for 48 h. Secreted CPY was detected on the filter by Western blot against CPY (Invitrogen, Carlsbad, CA).

CPY labeling and immunoprecipitation
------------------------------------

Cells were grown in SC-methionine at 30°C, and equal cell numbers (∼1 OD per time point) were labeled with 100 μCi/time point of \[^35^S\]methionine and chased with 50 mM methionine for the indicated times. Cell lysates were generated in 200 μl of 50 mM Tris-HCl, pH 7.5, 5 mM EDTA, and protease inhibitors by glass bead disruption. SDS was added to 0.5%, and lysates were boiled 5 min before addition of 800 μl of IP buffer (30 mM Tris-HCl, pH 7.5, 120 mM NaCl, 5 mM EDTA, 1% Triton X-100). Immunoprecipitates (IPs) were cleared by centrifugation at 10,000 × *g* for 10 min, and 35 μl of Protein A/G PLUS Agarose (Qiagen, Valencia, CA) and 2 μl of CPY monoclonal antibody (Invitrogen) were added and incubated overnight at 4°C. IPs were washed extensively, first in IP buffer with 0.1% SDS, then in IP buffer plus 2 M urea, followed again by IP buffer with 0.1% SDS three more times. Samples were resuspended in SDS sample buffer and detected by SDS--PAGE/autoradiography.

Bgl2 and invertase labeling and immunoprecipitation
---------------------------------------------------

These were performed as described in [@B19]. Briefly, cells were grown in SC-methionine at 30°C (or 37°C as indicated for ts controls), and equal cell numbers (∼1 OD per time point for Bgl2 and 3 OD per time point for invertase) were labeled with 100 μCi/time point of \[^35^S\]methionine and chased with 50 mM methionine for the indicated times. In the case of invertase, cells were cultured in SC-methionine containing 0.1% glucose for 15 min before and during the labeling. At the indicated times cells were removed and added to 2× stop/spheroplasting buffer (2 M sorbitol, 50 mM Tris-HCl, pH 7.4, 40 mM NaN~3~, 40 mM NaF, 1 mg/ml bovine serum albumin). After 10 min on ice, 1 μl of β-mercaptoethanol and 30 μg of zymolyase were added, and spheroplasts were generated at 37°C for 20 min with gentle shaking. Cells were separated from cell walls by centrifugation at 5000 × g for 5 min, and cell wall proteins were TCA precipitated. Cell pellets and TCA pellets were resuspended in 100 μl of SDS/urea buffer (50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1% SDS, 6 M urea), incubated at 100°C for 4 min, and 900 μl of IP buffer (50 mM Tris-HCl, 0.1 mM EDTA, 150 mM NaCl, 1% NP40) was added. Cell lysates were cleared by centrifugation at 16,000 × g for 10 min at 4°C. Immunoprecipitations were performed overnight at 4°C with 30 μl of Protein A/G PLUS Agarose and 1 μl of Bgl2 (from Randy Schekman) or invertase (from Howard Riezman, University of Geneva, Geneva, Switzerland) antibody. Immunoprecipitations were washed as described, resuspended in SDS sample buffer, and detected by SDS--PAGE/autoradiography.

Subcellular fractionation
-------------------------

Approximately 150 OD~600~ of wild-type and *cof1-8* cells cultured in YPDA at 30°C were harvested by centrifugation at 3000 × *g*, washed once with ice-cold 10 mM NaN~3~/NaF, and further incubated on ice in NaN~3~/NaF. Cells were resuspended at 20 OD/ml in pre-spheroplasting buffer (10 mM NaN~3~, 10 mM NaF, 100 mM Tris-H~2~SO~4~, pH 9.4, 0.36 μl/ml β-mercaptoethanol), and incubated for 20 min at 25°C. Cells were collected and spheroplasted at 50 OD~600~/ml in spheroplasting buffer (40 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid \[HEPES\]--NaOH, pH 7.5, 1.4 M sorbitol, 1 μl/ml β-mercaptoethanol) by treatment with 50 U/OD~600mn~ zymolyase 100T for 45--60 min at 37°C. Efficiency of spheroplasting was monitored by measuring OD~600~ of a 1:1000 dilution in H~2~O versus spheroplast buffer, with a 10-fold reduction in OD~600~ indicating complete spheroplasting. Spheroplasts were harvested, resuspended in 1.5 ml of lysis buffer (10 mM HEPES-NaOH, 1 mM EDTA, 0.3 M sorbitol, protease inhibitors), and lysed by 30 strokes of a Dounce homogenizer. Lysates were cleared twice by centrifugation (600 × *g* for 3 min). Equal protein concentrations were loaded on top of a continuous sucrose gradient (10 ml of 30--60% sucrose in 10 mM HEPES-NaOH, 1 mM EDTA) and centrifuged for 18 h at 100,000 × *g*. Fractions of 1 ml were collected from the top, and proteins were separated by SDS--PAGE and analyzed by Western blotting using antibodies against Mnn9 (a gift from Yoichi Noda, University of Tokyo, Tokyo, Japan) and Kar2 (a gift from Mark Rose, Princeton University, Princeton, NJ). Protein bands were quantitated with the Odyssey 2.1 software for three independent experiments, and the averages were plotted using Prism software (GraphPad Software, La Jolla, CA).

Fluorescence microscopy
-----------------------

Cells were imaged with a Leica DMI6000B microscope (Leica, Wetzlar, Germany) equipped with a DFC 360 FX camera using an HCX Pl APO 100× 1.4 objective. Images were taken using Leica LAS AF software. Snc1-GFP and Pma1-GFP were expressed exogenously from their own promoters and visualized in live cells cultured at 30°C in SC-uracil. The plasmid expressing Snc1-GFP was a gift from Hugh Pelham (MRC Laboratory of Molecular Biology, Cambridge, UK), and Pma1-GFP was kindly provided by Annick Breton (CNRS \[Centre national de la recherche scientifique\], Bordeaux, France).

FM4-64 uptake and trafficking were determined as described previously ([@B56]) with slight modifications. Cells were grown in YPD at 30°C and directly labeled with FM4-64 or shifted to 37°C for 1 h before labeling with 40 μM FM4-64 (Invitrogen) for 15 min (at 30 or 37°C, respectively). Cells were washed and resuspended in fresh, prewarmed YPD and further incubated at 30 or 37°C for 45 min, and live cells were immediately visualized.

Actin was visualized by staining with phalloidin linked to Alexa 488 (Invitrogen). Cells were grown at 30°C in YPD and directly fixed or shifted to 37°C for 1 h. Cells were fixed in 3.7% formaldehyde for 30 min and washed in phosphate-buffered saline (PBS). Fixed cells were permeabilized for 15 min with 0.1% Triton X-100 in PBS with 2% bovine serum albumin (BSA), washed in PBS, and incubated with 0.2 U/ml Alexa 488--phalloidin in PBS with 2% BSA for 1 h at room temperature. Cells were washed again in PBS and visualized immediately or stored at 4°C for visualization later.

Immunocolocalization of Bgl2
----------------------------

The immunocolocalization experiments were performed on wild-type and *cof1-8* cells containing either genomic Anp1-RFP or expressing exogenously Sec7-DsRed (kindly provided by Scott Emr, Cornell University, Ithaca, NY), mCherry-Tlg1, or mCherry-Pep12 (kindly provided by David Katzmann, Mayo Clinic, Rochester, MN). Cells were grown in SC medium to logarithmic phase at 30°C and fixed for 30 min in 3.7% formaldehyde. Immunofluorescence was performed as described ([@B44]), with slight modifications. Cells were washed twice in 0.1 M potassium phosphate (pH 7.4) and 1.2 M sorbitol (phos/sorb) and resuspended in 1 ml of phos/sorb. Cells were treated with 50 mg/ml zymolyase 10 T and 2 ml of β-mercaptoethanol at 30°C for 30 min. Cells were harvested gently by centrifugation at 3000 rpm for 5 min, washed twice, and resuspended in 200--500 ml of phos/sorb. Polylysine (molecular weight, \>300,000; Sigma-Aldrich)-coated slides were prepared in advance by adding of 10 ml polylysine (1 mg/ml) to the well of a Teflon-printed microscope slide (Immuno-Cell, Mechelen, Belgium), incubating it at room temperature for 10 min, washing it with distilled water, and allowing it to air dry. Spheroplasted cells (∼20 ml) were spotted onto the coated slides and incubated at room temperature for 20 min. Cells were permeabilized by immersing the slide in ice-cold methanol for 6 min and ice-cold acetone for 30 s. Cells were immediately covered in PBS with 3% BSA for rehydration and blocking and incubated for 30 min at room temperature. Cells were treated with primary antibody in a humid chamber at 4°C overnight, washed three times for 10 min in PBS, and treated with secondary antibody for 2 h in the dark at room temperature. Cells were washed again three times for 10 min in PBS before mounting and visualization. A purified Bgl2 antibody (a gift from Patrick Brennwald, University of North Carolina at Chapel Hill, Chapel Hill, NC) was used at 1:1000, and anti-RFP mouse antibody (Abcam) was used at 1:500. Secondary antibodies were anti--mouse Alexa 594 and anti--rabbit Alexa 488 (Invitrogen), each used at 1:5000. Images were taken in three-dimensional stacks with 10--12 slices of 0.1--0.3 mm and subjected to Leica deconvolution software.

Immunolocalization of HA-Pma1
-----------------------------

The p*MET25-HA-PMA1* vector was kindly provided by Amy Chang (University of Michigan), and cells were treated as described, with minor modification ([@B36]). Cells were grown in repressing conditions to logarithmic phase, washed in distilled water, and grown in methionine-free medium to derepress the MET25 promoter to allow HA-PMA1 expression. Normally, 600 μM methionine is sufficient to repress the MET25 promoter, but concentrations up to 2 mM were used to avoid the low-level of expression observed in wild-type cells. Cells were fixed for 2 h in 0.1 M KPO~4~, pH 6.6, washed in the same buffer, and treated for immunofluorescence as described. The HA epitope was detected with a monoclonal HA antibody (Covance, Berkeley, CA) used at a concentration of 1:1000 and the secondary anti--mouse Alexa 488 (Invitrogen).

Serial dilutions to assess growth
---------------------------------

Cells were grown to logarithmic phase at 25°C, set to an OD~600~ of 0.1, and serially diluted three times. Cells were plated to appropriate medium (YPD or SC lacking uracil or leucine to select plasmids as required) using a 96-well replica plate and incubated at the indicated temperatures for 48--72 h. The *PMR1*--expressing vector was provided by Kyle Cunningham (Johns Hopkins University, Baltimore, MD) and contains *PMR1* under the control of its own promoter cloned in a *URA3*-marked 2μ vector.
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CPY

:   carboxypeptidase Y

HDSV

:   high-density secretory vesicle

LDSV

:   low-density secretory vesicle

PIP~2~

:   phosphatidylinositol 4,5-bisphosphate

SPCA

:   secretory pathway calcium ATPase

TGN

:   *trans*-Golgi network
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